Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
SARASOTA, Fla., March 14, 2017 -- Roper Technologies, Inc. (NYSE:ROP) announced that its Board of Directors has approved a dividend of $0.35 per share payable on April 21, 2017 to stockholders of record on April 7, 2017.
About Roper Technologies
Roper Technologies is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper designs and develops software (both software-as-a-service and licensed), and engineered products and solutions for healthcare, transportation, food, energy, water, education and other niche markets worldwide. Additional information about Roper is available on the Company’s website at www.ropertech.com.
Contact Information: Investor Relations +1 (941) 556-2601 [email protected]
